Galleri Multi-Cancer Early Detection Test

Galleri Multi-Cancer Early Detection Test

Multi-cancer early detection test

The earlier that cancer can be found, the higher the chance of successful treatment and survival. Yet, too often cancer goes undetected until it has progressed to an advanced stage.

In studies, the Galleri test has shown the ability to detect multiple cancers through a simple blood draw. Most of these cancers cannot be detected through current screening paradigms. When cancer was detected, the Galleri test localized the cancer signal with high accuracy, helping inform next steps to diagnosis.1

The Galleri test is intended to be complementary to, and not a replacement of, U.S. guideline-recommended cancer screening.

Galleri Named to TIME’s List of the Best Inventions of 2022
November 10, 2022

MENLO PARK, Calif., – Nov 10, 2022 – Today, TIME revealed its annual list of the Best Inventions, which features 200 extraordinary innovations changing our lives.

We are honored to have GRAIL’s Galleri® test named among the top inventions of 2022. The Galleri test is a multi-cancer early detection (MCED) test that can detect a shared cancer signal across more than 50 types of cancer1 through a simple blood draw.

Using next-generation genomic sequencing and machine-learning technologies, the Galleri test detects a signal associated with cancer and includes one or two predictions of where in the body the cancer signal originated.

“I am thrilled to see the Galleri test included in TIME’s list of best inventions of 2022,” said Bob Ragusa, chief executive officer at GRAIL. “We believe strongly in the importance of early cancer detection and the impact it can make on patients’ lives. This test is a promising new tool in our fight against cancer.”

To compile the list, TIME solicited nominations from TIME’s editors and correspondents around the world, and through an online application process, paying special attention to growing fields—such as the electric vehicle industry, medical care, and the metaverse. TIME then evaluated each contender on a number of key factors, including originality, efficacy, ambition, and impact.

Of the new list, TIME’s editors write: “The result is a list of 200 groundbreaking inventions (and 50 special mention inventions)—including life-mapping artificial intelligence, diamonds made from excess carbon in the air, and the most powerful telescope ever—that are changing how we live, work, play, and think about what’s possible.”

See the full list here: time.com/best-inventions-2022

1 Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation n-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167-1177.

Houston Concierge Medicine